Hepatic FASN deficiency may also alter lipid profiles and lipoprotein metabolism, and such effects may contribute to the fasting hypercholesterolemia apparent in ob/ob HKO mice and to the amelioration of hepatic steatosis in ob/ob HKO and Mc4r-KO HKO mice. This evidence concerns the gene MC4R and fatty liver disease.